University Of Washington
Clinical trials sponsored by University Of Washington, explained in plain language.
-
Keytruda trial for untreated lymphoma halted early
Disease control TerminatedThis phase II study tested the immunotherapy drug pembrolizumab (Keytruda) in 9 people with untreated follicular lymphoma or marginal zone lymphoma. The goal was to see if the drug could shrink tumors or slow the disease. However, the trial was terminated early, so we have very l…
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 23, 2026 11:58 UTC
-
Bladder cancer drug trial halted early after enrolling just 4 patients
Disease control TerminatedThis small study tested whether giving the drug sacituzumab govitecan before surgery could help people with a rare type of muscle-invasive bladder cancer. The drug targets cancer cells and delivers chemotherapy directly to them. Only 4 people took part before the study was stoppe…
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 12, 2026 12:07 UTC
-
Kidney cancer drug combo trial halted early – what we know
Disease control TerminatedThis early-stage trial tested a combination of two immunotherapy drugs, aldesleukin (IL-2) and pembrolizumab, in 6 people with advanced kidney cancer that had spread. The goal was to find the safest dose and see if the combination could shrink tumors. The study was terminated ear…
Phase: PHASE1 • Sponsor: University of Washington • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden oral cancer cells
Diagnosis TerminatedThis study tested a dye called tozuleristide that makes oral cancer cells glow under special light during surgery. The goal was to help surgeons see and remove all cancer while sparing healthy tissue. The trial included 8 adults with oral cavity cancer or high-grade dysplasia. Th…
Phase: PHASE1, PHASE2 • Sponsor: University of Washington • Aim: Diagnosis
Last updated Jun 15, 2026 18:56 UTC
-
Can a simple ear massage help cancer patients eat better?
Symptom relief TerminatedThis small pilot study tested whether applying acupressure to the ear could help improve appetite and prevent weight loss in people with advanced stomach, esophagus, or pancreatic cancer. The approach uses small adhesive pellets placed on specific ear spots to stimulate the nervo…
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 23, 2026 11:59 UTC
-
New program aims to help parents with advanced cancer talk to their kids
Symptom relief TerminatedThis study tested two educational programs for parents with late-stage cancer who have children aged 5 to 17. The programs were designed to improve parent-child communication and boost parents' confidence in managing the impact of cancer on their children. The goal was to reduce …
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 23, 2026 11:55 UTC
-
Tech boost for cancer depression care falls short in study
Symptom relief TerminatedThis study looked at whether adding technology to standard collaborative care helps cancer patients with depression. It involved 297 adults receiving cancer treatment who had significant depression symptoms. The approach used care managers and a psychiatrist to coordinate treatme…
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 05, 2026 12:06 UTC
-
Prostate cancer study explores genetic testing for better treatment guidance
Knowledge-focused TerminatedThis study offered genetic testing to men whose prostate cancer had spread to other parts of the body. Researchers looked for inherited gene changes linked to cancer risk and asked participants about their thoughts on testing. The goal was to learn if this approach works well and…
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:05 UTC
-
Can MRI predict breast cancer treatment success?
Knowledge-focused TerminatedThis study looked at whether special MRI scans can detect early signs that anti-HER2 therapy is working in women with HER2-positive breast cancer. Thirteen participants received one dose of trastuzumab before surgery, and researchers compared MRI changes to immune cell levels in …
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 22, 2026 11:55 UTC
-
Can a simple guide prevent firearm accidents in dementia patients?
Knowledge-focused TerminatedThis study tested a decision aid to help older adults with early dementia or depression and their families talk about safe firearm storage. Only 5 people took part before the study ended early. The goal was to see if the tool was easy to use and could help improve storage safety,…
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 17, 2026 12:05 UTC
-
Gene study may explain why some breast cancers resist hormone therapy
Knowledge-focused TerminatedThis study looked at whether a specific gene mutation (HSD3B1) changes how well the hormone therapy letrozole works in postmenopausal women with early-stage, hormone-sensitive breast cancer. Researchers measured changes in tumor markers before and after treatment. The trial was e…
Phase: PHASE4 • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:03 UTC
-
New scan could help doctors plan better liver cancer treatments
Knowledge-focused TerminatedThis study tested a special type of scan (SPECT/CT) to see how well it measures liver function in people with liver cancer who are getting radiation or surgery. The goal was to learn if this scan can help doctors see which parts of the liver are working well before, during, and a…
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:55 UTC